Aroa Biosurgery Ltd (OTC:AROAF) Filings

Aroa Biosurgery Ltd

Filings

FilingDateTypeFiled with
US CMS Confirms Symphony Outpatient Reimbursement RateNov 8, 2026GuidanceASX
Aroa Biosurgery H1 FY27 Results & Investor EventNov 3, 2026ResultsASX
AROA Appoints Mark Dunwoodie as CFONov 2, 2026Management or board changeASX
Change in substantial shareholding for ARXOct 18, 2026Other filingsASX
Molnlycke to Co-promote Endoform In the USOct 15, 2026Other filingsASX
Notification of cessation of securities - ARXOct 12, 2026FinancingASX
Investor Presentation - Symphony RCTOct 11, 2026Other filingsASX
Invite to Investor Webinar on Symphony RCTOct 6, 2026Other filingsASX
Investor Presentation - MASTRR Interim AnalysisOct 6, 2026Operations updateASX
Change in substantial holdingOct 6, 2026Ownership change noticeASX
Symphony Significantly Improves DFU HealingOct 4, 2026Other filingsASX
Invite to Investor Webinar on MASTRR Interim AnalysisSep 28, 2026Other filingsASX
Myriad MASTRR Study Reports Low Infection RatesSep 3, 2026Operations updateASX
Change of Director's Interest Notice - BWAug 27, 2026Ownership change noticeASX
Notification regarding unquoted securities - ARXAug 27, 2026Notification letterASX
Final Director's Interest Notice - JDAug 20, 2026Ownership change noticeASX
Results of Annual General MeetingAug 19, 2026Meeting outcomeASX
CEO Presentation - AGMAug 18, 2026Other filingsASX
Chairman's Address - AGMAug 18, 2026Meeting outcomeASX
Notification of cessation of securities - ARXAug 11, 2026FinancingASX
Notification regarding unquoted securities - ARXAug 11, 2026Other filingsASX
Change in substantial shareholding for ARXAug 6, 2026Other filingsASX
Notification regarding unquoted securities - ARXJul 27, 2026Other filingsASX
Commercial Leadership AppointmentsJul 27, 2026Management or board changeASX
FY26 Full Year Results PresentationMay 25, 2026ResultsASX
FY26 Appendix 4E and Full Year ResultsMay 25, 2026ResultsASX
ARX FY26 Preliminary ResultsApr 29, 2026ResultsASX
Symphony Randomised Control Trial CompleteMar 29, 2026Other filingsASX
AROA Business Update PresentationFeb 2, 2026GuidanceASX
AROA Business UpdateFeb 2, 2026Operations updateASX
Aroa Biosurgery H1 FY26 ResultsNov 24, 2025ResultsASX
Appendix 4D and Half Year ReportNov 24, 2025Interim reportASX
September 2025 Quarterly Report and Appendix 4COct 15, 2025Quarterly reportASX
June 2025 Quarterly Report and Appendix 4CJul 28, 2025Quarterly reportASX
FY25 Full Year Results PresentationMay 28, 2025ResultsASX
FY25 Appendix 4E and Full Year ResultsMay 28, 2025ResultsASX
March 2025 Quarterly Report and Appendix 4CApr 28, 2025Quarterly reportASX
December 2024 Quarterly Report and Appendix 4CJan 28, 2025Quarterly reportASX
Aroa Half Year Results PresentationNov 25, 2024Interim reportASX
Aroa Biosurgery Half Yearly Results H1 FY25Nov 25, 2024ResultsASX
September 2024 Quarterly Report and Appendix 4COct 21, 2024Quarterly reportASX
June 2024 Quarterly Report and Appendix 4CJul 23, 2024Quarterly reportASX
FY24 Full Year Results PresentationMay 20, 2024ResultsASX
FY24 Appendix 4E and Full Year ResultsMay 20, 2024ResultsASX
March 2024 Quarterly Report and Appendix 4CApr 29, 2024Quarterly reportASX
December 2023 Quarterly Report and Appendix 4CJan 29, 2024Quarterly reportASX
Aroa Biosurgery Half Yearly Results H1 FY24Nov 27, 2023ResultsASX
September 2023 Quarterly Report and Appendix 4COct 30, 2023Quarterly reportASX
June 2023 Quarterly Report and Appendix 4CJul 30, 2023Quarterly reportASX
FY23 Full Year Results PresentationMay 30, 2023ResultsASX
FY23 Appendix 4E and Full Year ResultsMay 30, 2023ResultsASX
March 2023 Quarterly Report and Appendix 4CApr 26, 2023Quarterly reportASX
AROA secures first FDA clearance for ENIVO systemApr 11, 2023Other filingsASX
December 2022 Quarterly Report and Appendix 4CJan 30, 2023Quarterly reportASX
Aroa Biosurgery Half Yearly Results H1 FY23Nov 28, 2022Interim reportASX
September 2022 Quarterly Report and Appendix 4COct 24, 2022Quarterly reportASX
June Quarterly Report and Appendix 4CJul 25, 2022Quarterly reportASX
FY22 Full Year Results PresentationMay 23, 2022ResultsASX
FY22 Appendix 4E and Full Year ResultsMay 23, 2022ResultsASX
March Quarterly Report and Appendix 4CApr 25, 2022Quarterly reportASX
December Quarterly Report and Appendix 4CJan 27, 2022Quarterly reportASX
Aroa Biosurgery Half Yearly Report H1 FY21Nov 24, 2021Interim reportASX
September Quarterly Report and Appendix 4COct 26, 2021Quarterly reportASX
Aroa delivers strong half, Myriad GPO winOct 5, 2021Other filingsASX
Investor PresentationJul 28, 2021Other filingsASX
Aroa Completes $47m Placement and Launches $5m SPPJul 28, 2021FinancingASX
Trading HaltJul 26, 2021Trading halt or suspensionASX
FY21 Full Year Results PresentationMay 24, 2021ResultsASX
Preliminary Final ReportMay 24, 2021ResultsASX
Aroa secures FDA clearance for new productApr 5, 2021Other filingsASX
S&P DJI Announces March 2021 Quarterly RebalanceMar 12, 2021Other filingsASX
Aroa Half Year ResultsNov 25, 2020Interim reportASX
Aroa Biosurgery Secures FDA Clearance for SymphonyJul 30, 2020Other filingsASX
European Approval Received for MyriadJul 29, 2020Other filingsASX